Works matching IS 00302414 AND DT 2023 AND VI 101 AND IP 12
Results: 12
Front & Back Matter.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 764, doi. 10.1159/000535850
- Publication type:
- Article
Contents Vol. 101, 2023.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. I, doi. 10.1159/000535209
- Publication type:
- Article
Erratum.
- Published in:
- 2023
- Publication type:
- Correction Notice
High-Mobility Group Box 1 Overexpression Predicts a Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Gastric Cancer by Activating TLR4/NF-κB Signaling.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 786, doi. 10.1159/000533927
- By:
- Publication type:
- Article
The Potential of Trastuzumab Deruxtecan as a Tissue Agnostic Drug.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 836, doi. 10.1159/000533866
- By:
- Publication type:
- Article
Adverse Metabolic Effects on Glucose in Patients Receiving Anamorelin Using a Japanese Claims Database.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 782, doi. 10.1159/000533539
- By:
- Publication type:
- Article
Significance of Ultra-Radical Surgery in Extensive Metastatic Ovarian Growing Teratoma Syndrome.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 773, doi. 10.1159/000533411
- By:
- Publication type:
- Article
Comparing COVID-19 Response Behaviors between a Cancer Patient Sample and a Population-Based Cancer-Free Sample in a Rural Midwestern State.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 808, doi. 10.1159/000533408
- By:
- Publication type:
- Article
Evaluation of Time to Onset and Outcome of Cardiac Adverse Events Associated with Nilotinib using Post-Marketing Surveillance.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 799, doi. 10.1159/000533325
- By:
- Publication type:
- Article
Evaluation of Time to Onset and Outcome of Lung Adverse Events Related to Pembrolizumab Using Marketing Surveillance.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 817, doi. 10.1159/000533302
- By:
- Publication type:
- Article
Retrospective Study of Treatment Patterns and Natural History of Patients with T1a/b N0 Triple-Negative Breast Cancers: A Single-Institution Experience.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 765, doi. 10.1159/000533149
- By:
- Publication type:
- Article
Efficacy of Autologous Hematopoietic Stem Cell Transplantation versus Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation for Follicular Lymphoma: Systematic Review and Meta-Analysis.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 822, doi. 10.1159/000532090
- By:
- Publication type:
- Article